share_log

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

SEC ·  Jul 26, 2023 22:56
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.